
Article 1 
This Regulation lays down rules for the application of preventive health measures for the control of Echinococcus multilocularis infection in dogs intended for non-commercial movement into  Great Britain.
Article 1a 
In this Regulation, “the Commission Implementing Regulation” means “Commission Implementing Regulation (EU) No 577/2013 on the model identification documents for the non-commercial movement of dogs, cats and ferrets, the establishment of lists of territories and third countries and the format, layout and language requirements of the declarations attesting compliance with certain conditions provided for in Regulation (EU) No 576/2013 of the European Parliament and the Council.
Article 2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 4 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 5 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 6 

1. The owner or authorised person as defined in points (c) and (d) of Article 3 of Regulation (EU) No 576/2013 shall ensure that dogs moved into  Great Britain  have undergone a treatment against mature and immature intestinal forms of the Echinococcus multilocularis parasite.
2. The treatment referred to in paragraph 1 shall be carried out within a period of not more than 120 hours and not less than 24 hours before the time of the dog's scheduled entry into  Great Britain  in accordance with paragraphs 3 and 4 of this Article.
3. The treatment referred to in paragraph 1 shall be administered by a veterinarian and shall consist of a medicinal product:
(a) which contains the appropriate dose of:
((i)) praziquantel, or
((ii)) other pharmacologically active substances, which alone or in combination, have been proven to reduce the burden of mature and immature intestinal forms of the Echinococcus multilocularis parasite in dogs at least as effectively as praziquantel; and
(b) which has been granted:
((i)) a marketing authorisation in accordance with  regulation 4 of the Veterinary Medicines Regulations 2013  or Article 3 of Regulation (EC) No 726/2004 of the European Parliament and of the Councilas it has effect in European Union law, as amended from time to time, or
((ii)) an approval or a licence by the competent authority of the third country of dispatch of the dog intended for non-commercial movement.
4. The treatment referred to in paragraph 1 must be certified in the relevant section of the identification document by:
(a) where paragraph 4A applies, the administering veterinarian;
(b) where paragraph 4B applies—
(i) an official veterinarian of the third country of departure; or
(ii) an authorised veterinarian, provided an official veterinarian of the third country of departure subsequently endorses the certification.
(4A.) This paragraph applies in the case of non-commercial movements of dogs into Great Britain from a third country listed in Part 1 of Annex 2 to the Commission Implementing Regulation, after movement to or transit through a third country which is not so listed.
(4B.) This paragraph applies in the case of non-commercial movements of dogs into Great Britain from a third country not listed in Part 1 of Annex 2 to the Commission Implementing Regulation.
Article 7 

1. By way of derogation from Article 6,  the appropriate authority  shall authorise the non-commercial movement into its  constituent territory  of dogs which have not been subjected to the preventive health measures provided those dogs are moved directly from:
(a) the territory of  a member State listed in Part 1 of the Annex to Regulation 2018/878; or
(b) the territory or part of the territory of  a member State listed in Part 2 of the Annex to Regulation 2018/878.
2. By way of derogation from Article 6(2)  the appropriate authority  may authorise the non-commercial movement into its  constituent territory  of dogs which have been subjected to the preventive health measures provided for:
(a) in Article 6(3) and in point (a) of Article 6(4), at least twice at an interval of a maximum of 28 days and the treatment is repeated thereafter at regular intervals not exceeding 28 days;
(b) in Article 6(3) and (4), not less than 24 hours before the time of entering, and not more than 28 days prior to the date of  leaving the constituent territory, in which case those dogs must enter and leave that constituent territory through a travellers’ point of entry designated by the appropriate authority for the purposes  of the checks referred to in Article 34(1) of Regulation (EU) No 576/2013.
3. If the appropriate authority makes  use of the derogation provided for in paragraph 2 , it  shall establish the conditions for the control of such movements and make them publicly available.
(4.) For the purposes of this Article, “Regulation 2018/878” means Commission Implementing Regulation (EU) 2018/878 adopting the list of Member States, or parts of the territory of Member States, that comply with the rules for categorisation laid down in Article 2(2) and (3) of Delegated Regulation (EU) 2018/772 concerning the application of preventative health measures for the control of Echinococcus multilocularis infection in dogs, as it has effect in European Union law, as amended from time to time.
Article 8 
Delegated Regulation (EU) No 1152/2011 is repealed.
References to the repealed Regulation shall be construed as references to this Regulation and shall be read in accordance with the correlation table in Annex II.
Article 9 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Article 8 shall apply from 1 July 2018.
...Done at Brussels, 21 November 2017.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX I
1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ANNEX II

Delegated Regulation (EU) No 1152/2011 This Regulation
Article 1 Article 1
Article 2(1) Article 3
Article 2(2) Article 7(1)(b)
Article 2(3) Article 7(1)(b)
Article 3(a) Article 2(3)(a)
Article 3(b) Article 2(3)(b)
Article 3(c) Article 2(3)(c)
Article 4 Articles 2(4) and 4(3)
Article 5(1)(a) Article 4(2)(a)
Article 5(1)(b) Article 4(2)(b)
Article 5(2) Article 4(2)(c)
Article 5(3)(a) Article 4(2)(d)
Article 5(3)(b) Article 4(3)(c)
Article 5(4) Article 4(2)(e)
Article 6(a) Article 5(2)(a)
Article 6(b) Article 5(2)(b)
Article 6(c) Article 5(2)(c)
Article 6(d) Article 5(3)(d)
Article 7(1) Article 6(1) and (2)
Article 7(2) Article 6(3)
Article 7(3)(a) Article 6(4)(a)(i)
Article 7(3)(b) Article 6(4)(b)
Article 8(1) Article 7(2)
Article 8(2) Article 7(3)
Article 9 —
Article 10 Article 9
Annex I —
Annex II Annex I